Skip to main content
Top
Published in: Journal of Occupational Medicine and Toxicology 1/2014

Open Access 01-12-2014 | Short report

Arsenic exposure is associated with DNA hypermethylation of the tumor suppressor gene p16

Authors: Guangming Lu, Huiwen Xu, De Chang, Zhenglai Wu, Xiaoyuan Yao, Shiying Zhang, Zhenlong Li, Jieben Bai, Qing Cai, Wen Zhang

Published in: Journal of Occupational Medicine and Toxicology | Issue 1/2014

Login to get access

Abstract

Background

Occupational and environmental exposure to inorganic arsenic leads to development of cancer and represents a significant health hazard in more than 70 countries. The underlying mechanism for arsenic-induced carcinogenesis remains unclear. Laboratory studies suggest that arsenic is a poor mutagen but may cause epigenetic silencing of key tumor suppressor genes such as p16 through DNA hypermethylation. However, the evidence for an association between human arsenic exposure and abnormal DNA methylation of tumor suppressor genes is lacking.

Findings

Paired case–control studies were conducted involving 40 individuals with high arsenic exposure and arsenicosis, 40 individuals with similarly high exposure to arsenic but without arsenicosis, and 40 individuals with normal exposure to arsenic. DNA methylation status of p16 was determined using methylation-specific PCR. Conditional logistic regression analysis showed that DNA hypermethylation of p16 gene was significantly associated with high arsenic exposure (Odds Ratio = 10.0, P = 0.0019) independently of the development of arsenicosis (Odds Ratio = 2.0, P = 0.1343).

Conclusions

High exposure of arsenic in human is positively linked to DNA hypermethylation of p16 gene, suggesting that epigenetic silencing of key tumor suppressor may be an important mechanism by which arsenic promotes cancer initiation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M: Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 1999, 107: 593–597. 10.1289/ehp.99107593PubMedCentralCrossRefPubMed Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M: Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 1999, 107: 593–597. 10.1289/ehp.99107593PubMedCentralCrossRefPubMed
2.
go back to reference Rahman M, Tondel M, Chowdhury IA, Axelson O: Relations between exposure to arsenic, skin lesions, and glucosuria. Occup Environ Med 1999, 56: 277–281. 10.1136/oem.56.4.277PubMedCentralCrossRefPubMed Rahman M, Tondel M, Chowdhury IA, Axelson O: Relations between exposure to arsenic, skin lesions, and glucosuria. Occup Environ Med 1999, 56: 277–281. 10.1136/oem.56.4.277PubMedCentralCrossRefPubMed
3.
go back to reference Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH: Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 1994, 16: 184–209.PubMed Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH: Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 1994, 16: 184–209.PubMed
4.
go back to reference Anetor JI, Wanibuchi H, Fukushima S: Arsenic exposure and its health effects and risk of cancer in developing countries: micronutrients as host defence. Asian Pac J Cancer Prev 2007, 8: 13–23.PubMed Anetor JI, Wanibuchi H, Fukushima S: Arsenic exposure and its health effects and risk of cancer in developing countries: micronutrients as host defence. Asian Pac J Cancer Prev 2007, 8: 13–23.PubMed
5.
go back to reference Bates MN, Smith AH, Hopenhayn-Rich C: Arsenic ingestion and internal cancers: a review. Am J Epidemiol 1992, 135: 462–476.PubMed Bates MN, Smith AH, Hopenhayn-Rich C: Arsenic ingestion and internal cancers: a review. Am J Epidemiol 1992, 135: 462–476.PubMed
6.
go back to reference Noda Y, Suzuki T, Kohara A, Hasegawa A, Yotsuyanagi T, Hayashi M, Sofuni T, Yamanaka K, Okada S: In vivo genotoxicity evaluation of dimethylarsinic acid in MutaMouse. Mutat Res 2002, 513: 205–212. 10.1016/S1383-5718(01)00313-8CrossRefPubMed Noda Y, Suzuki T, Kohara A, Hasegawa A, Yotsuyanagi T, Hayashi M, Sofuni T, Yamanaka K, Okada S: In vivo genotoxicity evaluation of dimethylarsinic acid in MutaMouse. Mutat Res 2002, 513: 205–212. 10.1016/S1383-5718(01)00313-8CrossRefPubMed
7.
go back to reference Rossman TG, Stone D, Molina M, Troll W: Absence of arsenite mutagenicity in E coli and Chinese hamster cells. Environ Mutagen 1980, 2: 371–379. 10.1002/em.2860020307CrossRefPubMed Rossman TG, Stone D, Molina M, Troll W: Absence of arsenite mutagenicity in E coli and Chinese hamster cells. Environ Mutagen 1980, 2: 371–379. 10.1002/em.2860020307CrossRefPubMed
8.
go back to reference Goering PL, Aposhian HV, Mass MJ, Cebrián M, Beck BD, Waalkes MP: The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci 1999, 49: 5–14. 10.1093/toxsci/49.1.5CrossRefPubMed Goering PL, Aposhian HV, Mass MJ, Cebrián M, Beck BD, Waalkes MP: The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci 1999, 49: 5–14. 10.1093/toxsci/49.1.5CrossRefPubMed
9.
go back to reference Mass MJ, Wang L: Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 1997, 386: 263–277. 10.1016/S1383-5742(97)00008-2CrossRefPubMed Mass MJ, Wang L: Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 1997, 386: 263–277. 10.1016/S1383-5742(97)00008-2CrossRefPubMed
10.
go back to reference Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP: Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A 1997, 94: 10907–10912. 10.1073/pnas.94.20.10907PubMedCentralCrossRefPubMed Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP: Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A 1997, 94: 10907–10912. 10.1073/pnas.94.20.10907PubMedCentralCrossRefPubMed
11.
go back to reference Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S: Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol Sci 2006, 91: 372–381. 10.1093/toxsci/kfj159CrossRefPubMed Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S: Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol Sci 2006, 91: 372–381. 10.1093/toxsci/kfj159CrossRefPubMed
12.
go back to reference Jones PA, Gonzalgo ML: Altered DNA methylation and genome instability: a new pathway to cancer? Proc Natl Acad Sci U S A 1997, 94: 2103–2105. 10.1073/pnas.94.6.2103PubMedCentralCrossRefPubMed Jones PA, Gonzalgo ML: Altered DNA methylation and genome instability: a new pathway to cancer? Proc Natl Acad Sci U S A 1997, 94: 2103–2105. 10.1073/pnas.94.6.2103PubMedCentralCrossRefPubMed
13.
go back to reference Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996, 85: 27–37. 10.1016/S0092-8674(00)81079-XCrossRefPubMed Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996, 85: 27–37. 10.1016/S0092-8674(00)81079-XCrossRefPubMed
14.
go back to reference Nelson AA, Tsao H: Melanoma and genetics. Clin Dermatol 2009, 27: 46–52. 10.1016/j.clindermatol.2008.09.005CrossRefPubMed Nelson AA, Tsao H: Melanoma and genetics. Clin Dermatol 2009, 27: 46–52. 10.1016/j.clindermatol.2008.09.005CrossRefPubMed
15.
go back to reference Licchesi JD, Westra WH, Hooker CM, Herman JG: Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin Cancer Res 2008, 14: 2570–2578. 10.1158/1078-0432.CCR-07-2033CrossRefPubMed Licchesi JD, Westra WH, Hooker CM, Herman JG: Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin Cancer Res 2008, 14: 2570–2578. 10.1158/1078-0432.CCR-07-2033CrossRefPubMed
16.
go back to reference Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996, 93: 9821–9826. 10.1073/pnas.93.18.9821PubMedCentralCrossRefPubMed Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996, 93: 9821–9826. 10.1073/pnas.93.18.9821PubMedCentralCrossRefPubMed
17.
go back to reference Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, Das S, Ghosh N, Chatterjee D: DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 2006, 89: 431–437. 10.1093/toxsci/kfj030CrossRefPubMed Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, Das S, Ghosh N, Chatterjee D: DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 2006, 89: 431–437. 10.1093/toxsci/kfj030CrossRefPubMed
18.
go back to reference Zhang AH, Bin HH, Pan XL, Xi XG: Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China. J Toxicol Environ Health A 2007, 70: 970–975. 10.1080/15287390701290808CrossRefPubMed Zhang AH, Bin HH, Pan XL, Xi XG: Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China. J Toxicol Environ Health A 2007, 70: 970–975. 10.1080/15287390701290808CrossRefPubMed
19.
go back to reference Rocco JW, Sidransky D: p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001, 264: 42–55. 10.1006/excr.2000.5149CrossRefPubMed Rocco JW, Sidransky D: p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001, 264: 42–55. 10.1006/excr.2000.5149CrossRefPubMed
20.
go back to reference Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM: DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011, 6: 828–837. 10.4161/epi.6.7.16500PubMedCentralCrossRefPubMed Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM: DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011, 6: 828–837. 10.4161/epi.6.7.16500PubMedCentralCrossRefPubMed
21.
go back to reference Xu R, Wang F, Wu L, Wang J, Lu C: A systematic review of hypermethylation of p16 gene in esophageal cancer. A systematic review of hypermethylation of p16 gene in esophageal cancer. Cancer Biomark 2013, 13: 215–226.PubMed Xu R, Wang F, Wu L, Wang J, Lu C: A systematic review of hypermethylation of p16 gene in esophageal cancer. A systematic review of hypermethylation of p16 gene in esophageal cancer. Cancer Biomark 2013, 13: 215–226.PubMed
22.
go back to reference Shima K, Nosho K, Baba Y, Cantor M, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S: Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. Int J Cancer 2011, 128: 1080–1094. 10.1002/ijc.25432PubMedCentralCrossRefPubMed Shima K, Nosho K, Baba Y, Cantor M, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S: Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. Int J Cancer 2011, 128: 1080–1094. 10.1002/ijc.25432PubMedCentralCrossRefPubMed
23.
go back to reference Guo JX, Hu L, Yand PZ, Tanabe K, Miyatalre M, Chen Y: Chronic arsenic poisoning in drinking water in Inner Mongolia and its associated health effects. J Environ Sci Health A Tox Hazard Subst Environ Eng 2007, 42: 1853–1858. 10.1080/10934520701566918CrossRefPubMed Guo JX, Hu L, Yand PZ, Tanabe K, Miyatalre M, Chen Y: Chronic arsenic poisoning in drinking water in Inner Mongolia and its associated health effects. J Environ Sci Health A Tox Hazard Subst Environ Eng 2007, 42: 1853–1858. 10.1080/10934520701566918CrossRefPubMed
24.
go back to reference Luo FJ, Luo ZD, Ma L: A study on the relationship between drinking water with high arsenic content and incidence of malignant tumour in Heihe Village, western part of Huhehot, Inner Mongolia. Zhonghua Liu Xing Bing Xue Za Zhi 1995, 16: 289–291.PubMed Luo FJ, Luo ZD, Ma L: A study on the relationship between drinking water with high arsenic content and incidence of malignant tumour in Heihe Village, western part of Huhehot, Inner Mongolia. Zhonghua Liu Xing Bing Xue Za Zhi 1995, 16: 289–291.PubMed
Metadata
Title
Arsenic exposure is associated with DNA hypermethylation of the tumor suppressor gene p16
Authors
Guangming Lu
Huiwen Xu
De Chang
Zhenglai Wu
Xiaoyuan Yao
Shiying Zhang
Zhenlong Li
Jieben Bai
Qing Cai
Wen Zhang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Occupational Medicine and Toxicology / Issue 1/2014
Electronic ISSN: 1745-6673
DOI
https://doi.org/10.1186/s12995-014-0042-5

Other articles of this Issue 1/2014

Journal of Occupational Medicine and Toxicology 1/2014 Go to the issue